case study: treating hr-positive and her2-negative breast cancer
Published 10 years ago • 7.5K plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
8:49
case study: treating her2-positive metastatic breast cancer, part i
-
11:25
case studies: treating metastatic breast cancer
-
4:45
case study: treating her2-positive metastatic breast cancer, part ii
-
3:52
case study: her2-positive oligometastatic breast cancer
-
6:30
case study: treating metastatic triple-negative breast cancer
-
1:37
dr. meisel on optimizing genomic assays in early-stage hr-positive, her2-negative breast cancer
-
7:00
upfront treatment of hr-positive metastatic breast cancer
-
8:59
guidelines and approaches to her2 testing for breast cancer
-
1:26
dr. yardley on challenges with resistance mechanisms in hr /her2- breast cancer
-
1:51
dr. denduluri on treatment approaches in early-stage hr /her2- breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
13:15
metastatic hr breast cancer
-
0:52
dr. graff on genomic risk prediction in hr /her2- breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
8:41
cleopatra: treating her2-positive breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
30:49
conceptualizing guidelines to manage patients with hr–positive, her2-negative early breast cancer